Patents by Inventor Manfred Peukert

Manfred Peukert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040138138
    Abstract: The invention concerns the use of appropriate doses of an LHRH-antagonist to lower sex hormone levels resulting in a modification of the T-cell population in an individual suffering from a disease that will respond favourably to such modification. A preferred LHRH-antagonist is cetrorelix.
    Type: Application
    Filed: July 30, 2002
    Publication date: July 15, 2004
    Inventors: Jurgen Engel, Manfred Peukert
  • Publication number: 20040024048
    Abstract: The invention relates to the use of &agr;-lipoic acid in reduced or oxidized form or derivatives thereof with intact dithiolane structure in the form of enantiomers or pharmaceutically acceptable salts, amides, esters, thioesters, ethers or metabolites for the adjuvant therapy of dementias.
    Type: Application
    Filed: May 20, 2003
    Publication date: February 5, 2004
    Inventors: Klaus Wessel, Gerald Munch, Klaus Hager, Marlene Kenklies, Michael Lobisch, Manfred Peukert, Harald Borbe, Andreas Marahrens
  • Patent number: 6251935
    Abstract: The invention relates to the use of racemic &agr;-lipoic acid or its enantiomers or pharmaceutically acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized form, as active ingredient in the prevention or the acute or chronic treatment of migraine.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: June 26, 2001
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Jean Schoenen, Jürgen Engel, Klaus Wessel, Manfred Peukert, Michael Lobisch, Harald Borbe